Co-infection of Central Nervous System by M. Tuberculosis, Cryptococcus and possibly Naegleria fowleri

K Ravinder1, B Uppal1, P Aggarwal1

  • 1Department of Microbiology, Maulana Azad Medical College, New Delhi- 110002, India.

Tropical Biomedicine
|February 13, 2021
PubMed

Insights

This case report details a rare central nervous system co-infection involving Mycobacterium tuberculosis, Cryptococcus, and Naegleria fowleri in an immunocompetent adolescent. The findings underscore the need to consider unusual pathogens in non-responsive meningitis cases.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Microbiology

Background:

  • Central nervous system (CNS) co-infections involving pathogens from different kingdoms are exceptionally rare.
  • Mycobacterium tuberculosis, Cryptococcus, and Naegleria fowleri are distinct pathogens causing severe neurological conditions.
  • Co-infection with these three specific agents has not been previously documented in medical literature.

Purpose of the Study:

  • To report the first known case of CNS co-infection with Mycobacterium tuberculosis, Cryptococcus, and Naegleria fowleri.
  • To highlight the diagnostic challenges and clinical implications of such a rare co-infection in an apparently immunocompetent individual.
  • To emphasize the importance of considering rare etiologies in refractory CNS infections.

Main Methods:

  • Case presentation of a 15-year-old male with diagnosed tubercular meningitis.
  • Cerebrospinal fluid (CSF) analysis including microscopy for yeast and parasites, and Latex Agglutination test for Cryptococcal antigens.
  • Brain CT and MRI scans to assess neurological damage.
  • Treatment with anti-tubercular therapy, anti-epileptic drugs, and amphotericin B.

Main Results:

  • The patient presented with altered consciousness, and CSF analysis revealed Mycobacterium tuberculosis (presumed from prior diagnosis), Cryptococcus (yeast cells, positive antigen test), and Naegleria fowleri (flagellated parasites).
  • The patient was HIV-negative and appeared immunocompetent.
  • Despite a six-week course of amphotericin B and CSF clearing, neurological improvement was limited due to pre-existing damage.

Conclusions:

  • This case represents a unique CNS co-infection involving three pathogens from different kingdoms in an immunocompetent host.
  • The findings stress the critical need for broad diagnostic consideration and investigation of rare pathogens, particularly in cases of CNS infections that do not respond to standard treatments.
  • Early identification and intervention for unusual co-infections are crucial for improving patient outcomes, despite potential for irreversible neurological sequelae.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
869
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
256
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
498
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
278
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
605
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
321